Global Smart Inhaler Technology Market 2018-2022
About Smart Inhaler Technology
The smart inhaler technology uses sensors and requires a smartphone or a computer-based app, which can be integrated into any metered-dose inhaler (MDI) or dry-powder inhaler (DPI) inhaler to convert it into a smart inhaler. The sensors used in smart inhalers can be connected to the user's smartphone or computer to provide information on the dosages, frequency, and medications required by the user.
Technavio’s analysts forecast the global smart inhaler technology market to grow at a CAGR of 51.35% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global smart inhaler technology market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Smart Inhaler Technology Market 2018-2022
Technavio recognizes the following companies as the key players in the global smart inhaler technology market: 3M, Adherium, Propeller Health, and Teva Pharmaceuticals.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing exposure to air pollution and tobacco smoking. COPD is a progressive and eventually debilitating lung disease, which leads to worse lung conditions over time. The disease usually causes coughing, wheezing, and shortness of breath. Smoking triggers exacerbation, flare-up, or breathing difficulties in COPD patients.”
According to the report, one driver in the market is rising prevalence of COPD and asthma. Respiratory diseases affect various organs in the respiratory system such as the pharynx, larynx, trachea, lungs, and bronchi. COPD and asthma can lead to medical complexities such as difficulty breathing, chronic cough, fatigue, and chest tightening, which can be treated by MDIs and DPIs for a short-term and long-term cure.
Further, the report states that one challenge in the market is low awareness and product penetration in developing countries. Smart inhalers are innovative products that have limited market presence in the developing countries. The major growth impeding factor for limited market presence is the lack of awareness among the end-users. The lack of knowledge about connected healthcare systems and the low adoption rates of advanced technological platforms among the users of traditional inhalers are impeding market growth in the developing countries.
Other prominent vendors
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook